@Singapore88. Not seen yet..... Maybe the forces of buyer comes from the retail investors + small sharks/bankers. If there is a big investor, they will hold 5% or more shareholding, therefore will be announced at BURSA as a substantial share holder.
Attention:- Very HOT now !! Please come to join our telegram forum discussion group, more articles, graph, news in our group to be shared. You can search 《NXGRAM CLUB》
FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar
(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.
The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.
"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.
The 13 Covid-19 vaccines in the final stages of testing to be used in Malaysia Category: Inactivated virus vaccines 1. Sinovac 2. Wuhan Institute of Biological Products / Sinopharm, 3. Beijing Institute of Biological Products / Sinopharm 4. Bharat Biotech Category: Non-replicating viral vector vaccines 5. University of Oxford / AstraZeneca 6. CanSino Biological Inc / Beijing Institute of Biotechnology 7. Gamaleya Research Institute Russia’s Gamaleya National Center of Epidemiology and Microbiology said the Sputnik V vaccine candidate it developed involves what it described as a unique method of using two different types of adenovirus vectors (rAd26 and rAd5) for the first and second doses of vaccination with the aim of producing a stronger and longer-term immune response. The doses are said to be given 21 days apart. Gamaleya Center claims Sputnik V to have an efficacy rate of more than 90 per cent. On November 24, Russia’s sovereign wealth fund Russian Direct Investment Fund (RDIF) said the cost of Sputnik V in international markets will be less than US$20 for two doses, while the freeze-dried form of the vaccine candidate is said to be able to be stored at a temperature of between 2 to 8 degrees Celsius. According to the Gamaleya Center and RDIF, a Phase III trial in Russia involving 40,000 volunteers is underway, and Phase III trials are also ongoing in other countries such as Belarus, the UAE and Venezuela, while a Phase II-III trial is being undertaken in India. 8. Janssen Pharmaceutical Companies Category: Protein-based vaccines 9. Novavax 10. Anhui Zhifei Longcom Biopharmaceutical / Institute of Microbiology, Chinese Academy of Sciences Category: RNA / DNA vaccines 11. Moderna / NIAID 12. Pfizer / BioNTech / Fosun Pharma 13. Medicago Inc
TITLE:.. A THEORY ABOUT A JOINT VENTURE BETWEEN VACCINE LAB (s/o NEXGRAM) WITH RAFARMA (US company)
(To open a vaccine facility in Indonesia to research, develop, conduct clinical trials and license for various in-demand vaccines including Covid-19)
RESEARCH QUESTION:
Which Covid-19 Vaccine candidates is going to be secured by the JV ?
HYPOTHESIS:
Based on the JV, there is a probability on the JV to cater any Covid-19 Vaccine candidate which can be conducted clinical trials and license for produced in Indonesia, and distributed by the JV to Indonesia and the other ASEAN countries.
THE JV:
R. & D. Biocogency Laboratories Inc (Cyprus) (parent company of RAFARMA) I RAFARMA (US) ------------------------------- JV Vaccines Lab I PJSC Kraspharma(sub of RAFARMA) (Russia)
THEN:……..
A BIG BIG POSSIBILITY:
Vaccine Lab + Rafarma Pharmaceuticals (US) + R. & D. Biocogency Laboratories Inc. (Cyprus) + subsidiary of Rafarma, PJSC Kraspharma (Russia) ———-> Russian or other source country Covid-19 vaccine ———> Indonesia and the ASEAN countries
THE REASONS:…. 1. Based on BURSA announcement: VACCINESLAB and RAFARMA desire to jointly develop and conduct initial clinical trial and expanded clinical trial (“Clinical Trial”) and invest in LARGE-SCALE COVID-19 VACCINE FACILITY IN INDONESIA (“Vaccine Plant”) exclusively for the above and other various vaccines as well as other immunological promising drug, use developed by RAFARMA, especially clinical trials in regional trial sites outside of USA and China with this MSJVA.
2. THIS ONE I THINK IMPORTANT: ....... Penny Lukito, the head of Indonesia’s food and drugs agency, BPOM, told reporters on Thursday that the agency had also been approached by American pharmaceutical giant Pfizer and British firm AstraZeneca, as well as by THE DEVELOPER OF RUSSIA'S SPUTNIK V vaccines “to talk about the possibility of launching clinical trials for their Covid-19 vaccines in Indonesia”. ...... The Russian government had sent a letter to the Indonesia’s Health Ministry in September over the possibility of Sputnik V vaccine distribution, procurement and clinical trials. Preliminary results on the vaccine, which is currently in phase-three clinical trials, show its efficacy rate at 92 per cent, according to its developer, Gamaleya Research Institute.
3. ---- Indonesia said Thursday that it had been approached by several drug makers whose Covid-19 vaccine candidates have shown promising early results to either test or produce their vaccines, moving the country a step closer to becoming Southeast Asia’s vaccine production and distribution hub.
4. Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reported that one of the acquisition companies of the previously-announced Biocogency merger, Bebig LLC received an updated Russian registration certificate for the production and sale of nanostructured microspheres based on yttrium-90, used in the treatment of both primary and metastatic liver lesions.
CONCLUSION:…
The JV are not announcing any covid-19 vaccine yet. But based on my study, Rafarma has a subsidiary Kraspharma in Russia, which has a probabilty to cater vaccine from Russia— Sputnik V vaccine.
All are the relationship between Rafarma and the Russian Goverment. Linking: Rafarma in USA - Krasfarma in Russia -- Vaccinelab -- Russian Covid-19 vaccine candidate - Indonesia and the Asean countries.
And it also has a possibility to cater other Covid-19 vaccine candidates, including from China.
OKU_2020. I'm a long term investors (actually caused being trapped long time before but won't accept to cut loss or break even). Now I'm preparing to win big in this counter. He He He He He
THOSE RULE WON'T SUITS ME AND OTHER MEDIUM AND LONG TERM INVESTORS
Now already news...no more excitement...that's why this Cap Ayam Nexgram is losing steam & Kaput-ing now ... -----------------------------------------------------
I will wait for the news which will show the progress of the JV. Any good news, NEXGRAM KABOOOOOOOOOOOOOOM. What say you?
Please just offer us the facts or your true logic, not a naysayer ideas only.. He He He
@ MZM 2511...I'm a long term investors (actually caused being trapped long time before but won't accept to cut loss or break even). Now I'm preparing to win big in this counter. He He He He He ++++++++
@OKU_2020. mmm... Your know the Probability theory ?...MATH --------------------------------
Won't use probabilty theory. I'm trained in accounting and economics. Will use those theories. The past for Nexgram was over.
Emerge developments in the current and future businesses-- Show better financial conditions + Good rumours on the company --- Attract more investor -- The demand for the company shares exceeds supply ... THE PRICE OF THE COMPANY SHARES WILL APPRECIATE
THAT'S TRUE ESSENCE OF THE ACCOUNTING AND ECONOMICS THEORY
@OKU_2020. mmm... Your know the Probability theory ?...MATH --------------------------------
Tiada yang mustahil dalam saham. Kalau ikut teori probability, kemungkinannya sebelum ini sepatutnya RENDAH, tetapi yang berlaku sebaliknya.
1. GETS GLOBAL BERHAD dari 4.5 sen pada 23 Mac 2020 boleh mencecah setinggi RM3.97. 2. Lebih dekat lagi dengan Nexgram (already been a vaccine counter) ialah saham HWGB (sebab covid-19 vaksin) dari harga terendah 6 sen mencapai harga tertinggi RM1.03.
Brother ,,u have write up on bornoil,,like to buys ,can invest ----------------------------------- If want to invest please buy it as you think it is at its lower. Just my idea only
I will stick to my plans. Have to believe it. It's good for contrarrian. They come to nexgram counter, and its also gives me a pleasure. As a sign there will be a future days where so many investors will come and punter the stocks, more demand for it, BOOOOOOOM. Its my day to become half millionaire or at the best a millionaire. Insha Allah
@Singapore88. Good. But I never clearly stated my TP except more than 12 sen and above. Then I want to recap this.. He He -------------------------- MZM2511 rumours..... By the way, sifu paktua73 tut tut just predicted Nexgram's price can go to @50 sen on April 2021. He He
Dari bilik sebelah: ----------------------------------------- paktua73, [12.12.20 10:16] morning all nxgram warriors.. after paktua study the rally pattern for nxgram.. this paktua own personal view..
nexgram will start rally on jan after all vaccines start hot
paktua will start fight here on mid jan
paktua73, [12.12.20 10:18] paktua aimed rm 0.50 on april (personal target yer
@OKU_2020. mmm... Your know the Probability theory ?...MATH --------------------------------
Tiada yang mustahil dalam saham. Kalau ikut teori probability, kemungkinannya sebelum ini sepatutnya RENDAH, tetapi yang berlaku sebaliknya.
1. GETS GLOBAL BERHAD dari 4.5 sen pada 23 Mac 2020 boleh mencecah setinggi RM3.97. 2. Lebih dekat lagi dengan Nexgram (already been a vaccine counter) ialah saham HWGB (sebab covid-19 vaksin) dari harga terendah 6 sen mencapai harga tertinggi RM1.03.
@char1234. Even the dead company can be transformed it to be alive. Nexgram never died, it just have many problems in the past few years. Think about it wisely Dear Friend.
Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight
Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans
Yess.. "Tiada yang mustahil dalam saham "... the Odd@Probability to hit RM 1 is 1 %..=...0.01 limit to 0 say MATH 101 . That's why till now " tok lehh Pitih $ " - Kena Preqq Sokmo
Very Old fashioned Grandma - Old School - !
Wait till Cats Grow Horn ( Kucing Tumbuh Tandok ) with Pak Tua Toot Toot
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 630 views | 12 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
limit_up
333 posts
Posted by limit_up > 2020-12-11 20:25 | Report Abuse
Ozura will stop disposing. Not a substantial holder anymore.
Nexgram will fly...